Reviva: Developing Next-Generation Therapies for Diseases with Significant Unmet Needs
Reviva Pharmaceuticals (Nasdaq: RVPH) is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva's current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva's pipeline currently has two drug candidates, RP5063 (Brilaroxazine) and RP1208. Both are new chemical entities discovered in-house. Topline data for pivotal Phase 3 trial evaluating brilaroxazine for the treatment of schizophrenia remains on track for mid-2023. Learn more at RVPHinfo.com.
Transcription:
A Phase 3 clinical-stage biopharma, Reviva Pharmaceuticals poised to disrupt markets worth billions - from schizophrenia to depression, ADHD, and beyond. With top-line data from a pivotal Phase 3 trial due in Q3 2023, the time to act is now. Learn more at RVPHinfo.com.
-
1:57
RedChip
10 months agoReviva: Providing a Major Breakthrough for Mental Health and Schizophrenia
8 -
10:21
RedChip
8 months agoReviva: Announcing Completion of Enrollment of Pivotal Phase 3 Trial
7 -
4:13
The Igonrant Entrepreneur
11 months agoThe First AI-Generated Drug Enters Human Trials, Pioneering a New Era in Medicine!
22 -
1:17
Emily Bron
25 days agoInnovative Medical Breakthroughs and Regulatory Challenges in Pharmaceuticals
1 -
3:35
Atomic Analyzer
6 months agoCRISPR Milestone: UK Approves the Revolutionary Treatment for Genetic Diseases
611 -
2:43
Just the News
1 year agoFDA considers gene therapy to treat rare muscle disease
1.86K1 -
54:08
ProgressPotentialAndPossibilities
1 year agoDr. Michael Hufford, PhD - Advancing Novel Therapeutic Interventions For Unmet Medical Needs
13 -
2:55
NewsUpdate
1 year agoNew treatment hailed as major breakthrough in fighting Alzheimer’s
44 -
3:59
Atomic Analyzer
7 months agoBeyond COVID-19 vaccines: what else could mRNA technology do for our health?
591 -
2:26
galacticstorm
8 months agoShane Ellison: The big pharma business model's next level: INVENT DISEASE.
325